Xtant Medical Holdings, Inc. (XTNT): Price and Financial Metrics
GET POWR RATINGS... FREE!
XTNT POWR Grades
- Growth is the dimension where XTNT ranks best; there it ranks ahead of 94.94% of US stocks.
- XTNT's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
- XTNT's current lowest rank is in the Momentum metric (where it is better than 15.14% of US stocks).
XTNT Stock Summary
- XTNT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 3.24% of US stocks.
- With a year-over-year growth in debt of -77.02%, Xtant Medical Holdings Inc's debt growth rate surpasses just 3.79% of about US stocks.
- In terms of volatility of its share price, XTNT is more volatile than 89.56% of stocks we're observing.
- Stocks that are quantitatively similar to XTNT, based on their financial statements, market capitalization, and price volatility, are ALIM, CMPR, TXMD, ADMS, and USWS.
- XTNT's SEC filings can be seen here. And to visit Xtant Medical Holdings Inc's official web site, go to www.xtantmedical.com.
XTNT Stock Price Chart Interactive Chart >
XTNT Price/Volume Stats
| Current price | $1.78 | 52-week high | $6.58 |
| Prev. close | $1.72 | 52-week low | $0.71 |
| Day low | $1.68 | Volume | 90,000 |
| Day high | $1.80 | Avg. volume | 2,501,317 |
| 50-day MA | $1.80 | Dividend yield | N/A |
| 200-day MA | $1.62 | Market Cap | 154.34M |
Xtant Medical Holdings, Inc. (XTNT) Company Bio
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company is based in Montana.
Latest XTNT News From Around the Web
Below are the latest news stories about Xtant Medical Holdings Inc that investors may wish to consider to help them evaluate XTNT as an investment opportunity.
Xtant Medical Holdings, Inc. to Host Earnings CallNEW YORK, NY / ACCESSWIRE / May 11, 2021 / Xtant Medical Holdings, Inc. (NYSE:XTNT) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 11, 2021 at 9:00 AM Eastern Time. |
Xtant Medical Announces First Quarter 2021 Financial ResultsBELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2021. First Quarter 2021 Financial Highlights: Revenue for the first quarter of 2021 totaled $12.5 million, compared to $14.8 million for the prior-year periodOperating expenses in the first quarter of 2021 totaled $8.1 million, compared to $11.0 million for the prior-year periodLoss from operations totaled $5,000 compared to an operating loss of $1.4 million for the prior-year periodNet loss incurred in the first quarter of 2021 totaled $29,000 compared to a net loss of $2.5 million for the prior-ye... |
Xtant Medical Files $150 Million Shelf Registration StatementBELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today it has filed a universal shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). Under the shelf registration, upon being declared effective by the SEC, Xtant may offer and sell, from time to time over a three-year period, various securities in an amount of up to $150 million. In addition, the registration statement, upon effectiveness, will allow certain stockholders affiliated with OrbiMed Advisors, LLC to offer and sell, from time to time, up to 18,218,374 shares of Xtant common stock. The shelf registration statement is intended... |
Xtant Medical Announces $20 Million Debt Financing with MidCap FinancialBELGRADE, Mont., May 06, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company and its subsidiaries have entered into credit agreements with MidCap Financial Trust (“MidCap”). The credit agreements provide for a $12 million secured term loan at a per annum interest rate of 7.00%, plus one-month LIBOR, and an $8 million secured revolving credit facility at a per annum interest rate of 4.50%, plus one-month LIBOR. Both facilities have a five-year term. These new credit agreements replace the Company’s second amended and restated credit agreement, as subsequently amended, with OrbiMed Royalty Opportunities II, LP as lender (in such... |
Xtant Medical to Issue First Quarter 2021 Financial Results on May 11, 2021BELGRADE, Mont., May 04, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2021, before the open of the financial markets on Tuesday, May 11, 2021. Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Tuesday, May 11 at 9:00 AM ET to review results. Conference DetailsConference Date: Tuesday, May 11, 2021 - 9:00 AM ETConference dial-in: 877-407-6184International dial-in: 201-389-0877Conference Call Name: Xtant Medical Q1 2021 Financial ResultsWebcast Registration:... |
XTNT Price Returns
| 1-mo | 17.11% |
| 3-mo | -37.32% |
| 6-mo | 52.14% |
| 1-year | 63.30% |
| 3-year | -70.96% |
| 5-year | -93.07% |
| YTD | 48.82% |
| 2020 | -25.24% |
| 2019 | -0.62% |
| 2018 | -76.46% |
| 2017 | 3.64% |
| 2016 | -80.36% |
Continue Researching XTNT
Want to see what other sources are saying about Xtant Medical Holdings Inc's financials and stock price? Try the links below:Xtant Medical Holdings Inc (XTNT) Stock Price | Nasdaq
Xtant Medical Holdings Inc (XTNT) Stock Quote, History and News - Yahoo Finance
Xtant Medical Holdings Inc (XTNT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...